Aptuit has appointed Jonathan Goldman, M.D., as CEO. Goldman will focus on the growth of Aptuit as a provider of outsourced services in the early development space by establishing new partnerships with clients and pursuing strategic acquisitions. He joins the company after success at Icon Clinical Research, a global CRO specializing in the provision of clinical and other solutions that support phase I-IV clinical studies.
At Icon, Goldman was most recently executive vice president, global strategic and business development and a member of the senior leadership team. His accomplishments included record growth levels of sales, and the development of transformative business relationships with pharmaceutical and biotechnology companies. Previously, his roles at Icon included executive vice president, operations, strategic programs and chief medical officer, Icon Medical Imaging.
Goldman, for seven years, worked as the chief medical officer of Point Biomedical, a U.S.-based biopharmaceutical company that discovered and developed microsphere technologies and drugs. In addition, he has held honorary academic positions of increasing responsibility at the University of California since 2000, most recently as associate clinical professor of medicine in the division of cardiology.